Ann d. Rhoads

Ann d. Rhoads, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in QuidelOrtho Corp, Globus Medical Inc and Quidel Corp. We count 18 filings; the first trade dates from 12 May 2021 and the latest from 28 January 2026.

The open-market side counts 1 purchase for €18k alongside 3 sales for €1.6M. Taken together, the sales exceed the purchases by €1.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 8 share grants and 4 option exercises.

On 28 January 2026 came the latest disclosure, a transaction in Repare Therapeutics Inc. The latest purchase dates back some time: it was published 312 days ago, on 10 December 2025. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.